all bombay times print stories are available on
.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
.
now the country may face a fine of millions of euros after its dereliction was referred to the european court of justice (ecj), the guardian reports.
. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.